TWiV 1303: Overachieving vaccines

Shingles vaccination correlates with slower biological aging and reduced dementia risk, potentially by mitigating chronic inflammation and immune dysregulation. Beyond pathogen-specific protection, shingles, influenza, and pneumococcal vaccines appear to influence multi-system biological aging markers, including epigenetic and transcriptomic profiles. Furthermore, intranasal mucosal vaccination using toll-like receptor agonists and specific antigens induces broad, non-specific protection against diverse respiratory pathogens in mice. This mechanism relies on a feed-forward circuit where antigen-specific T-cells interact with alveolar macrophages, enhancing their antigen-presenting capacity and promoting the formation of tertiary lymphoid structures in the lungs. While these findings suggest a conceptual shift toward using vaccines as broad-spectrum tools for healthy aging and pandemic preparedness, further longitudinal research is required to determine the durability and clinical significance of these effects in humans.